Global Tuberculosis Screening Market Growth (Status and Outlook) 2025-2031

The global Tuberculosis Screening market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Tuberculosis Screening is crucial for early diagnosis and prevention. Market trends include the adoption of advanced diagnostic technologies, such as molecular assays and point-of-care tests, to improve accuracy and speed of diagnosis. There"s also a growing emphasis on screening in high-risk populations and in regions with a high TB burden.

LPI (LP Information)' newest research report, the “Tuberculosis Screening Industry Forecast” looks at past sales and reviews total world Tuberculosis Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Screening sales for 2025 through 2031. With Tuberculosis Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Screening industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:

Active Tuberculosis

Latent Tuberculosis

Segmentation by Application:

Hospital

Clinic

Diagnostic Center

Laboratories

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Qiagen

Sanofi

Oxford Immunotec

BioMerieux

Par Sterile

Bio-Rad Laboratories

Akonni Biosystems

Becton Dickinson

Abbott

Hologic

Roche

Thermo Fischer Scientific

Hain Lifescience

Epistem

Creative Diagnostics

Cepheid

Siemens Healthineer

Please note: The report will take approximately 2 business days to prepare and deliver.